WELCOME TO MEDSHADOW. WE'VE UPDATED OUR LOOK!

FDA Encouraging Industry to Make More Opioid Abuse Therapies

FDA Encouraging Industry to Make More Opioid Abuse Therapies
FDA Encouraging Industry to Make More Opioid Abuse Therapies

The FDA is working toward making therapies for opioid use disorder more readily accessible by advising pharmaceutical companies to limit the number of times they conduct clinical trials on particular proposed treatments.

The FDA published a draft guidance indicating that certain “depot buprenorphine products” may not require additional efficacy and safety opioid studies in certain instances because the agency may have approved a similar product that already underwent clinical testing.

“Unfortunately, far too few people who suffer from opioid use disorder are offered an adequate chance for treatment that uses safe and effective medications,” said FDA Commissioner Scott Gottlieb, MD, in a statement.

“The FDA will continue to encourage more widespread innovation and development of new and better treatments for opioid addiction as well as tackle the unfortunate stigma that’s sometimes associated with use of these treatments.”

On the other hand, if certain depot buprenorphine products require additional clinical testing, then drugmakers would have to show that their product is identical to the drug that has already been approved instead of proving that it is safe and effective.

The FDA will publish further guidance detailing the types of clinical outcomes that will be measured and evaluated for future treatment approvals.

DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.

While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual's medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.

Was This Article Helpful?

Show Comments (0)
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x